Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pharmaids Pharmaceuticals (BOM:524572) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Pharmaids Pharmaceuticals Quick Ratio Related Terms
Pharmaids Pharmaceuticals Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Pharmaids Pharmaceuticals's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaids Pharmaceuticals Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Pharmaids Pharmaceuticals's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Pharmaids Pharmaceuticals's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Pharmaids Pharmaceuticals's Quick Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaids Pharmaceuticals (BOM:524572) has a Quick Ratio of 0.00 as of Jun. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Pharmaids Pharmaceuticals and its competitors. Over the past decade, Pharmaids Pharmaceuticals' Quick Ratio has ranged from 0.35 to 675.19. According to the industry distribution chart, Pharmaids Pharmaceuticals ranks #909 out of 994 companies in the Drug Manufacturers industry, placing it in the top 91.4%.
Is Pharmaids Pharmaceuticals' Quick Ratio too high?
Pharmaids Pharmaceuticals' current Quick Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 675.19. Based on the distribution chart, Pharmaids Pharmaceuticals ranks #909 out of 994 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Pharmaids Pharmaceuticals has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Pharmaids Pharmaceuticals' Quick Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Pharmaids Pharmaceuticals ranks #909 out of 994 companies for Quick Ratio. This places Pharmaids Pharmaceuticals in the lower half of its industry. The industry median Quick Ratio is 1.44. Historically, Pharmaids Pharmaceuticals' own Quick Ratio has ranged from 0.35 to 675.19 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.44, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Pharmaids Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaids Pharmaceuticals's current Quick Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaids Pharmaceuticals stock overvalued right now?
Pharmaids Pharmaceuticals (BOM:524572) has a current Quick Ratio of 0.00. The current Quick Ratio is 0.00. Pharmaids Pharmaceuticals' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Pharmaids Pharmaceuticals (BOM:524572), the current Quick Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmaids Pharmaceuticals Ltd is an Indian pharmaceutical company that manufactures specialty chemicals, skin care products, hospital care products, and generic drugs. Its product range includes vitamins and related compounds, hand sanitizers, antiseptic solutions, ointments, and various bulk drugs. The company operates from Hyderabad, India, serving domestic and select international markets. Pharmaids generates revenue prominently from the sale of these pharmaceutical and healthcare products. Its operations focus on manufacturing and supplying formulations across healthcare and personal care segments.
23GF Score
Get the complete analysis for BOM:524572
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524572 has been successfully added to your 
